Company Description
Biodelivery Sciences International, Inc.. The Group's principal activity is to develop and design drug delivery technology for pharmaceuticals, vaccines and over-the-counter drugs. The proposed drug delivery technology encapsulates or wraps the ...
Related Business Topics
Breaking News
Reuters - November 12, 2009 6:46 AM
RALEIGH, N.C.--(Business Wire)-- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President & Chief Executive Officer, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference to be ...
Forbes.com - November 12, 2009 6:24 AM
BusinessWire - BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President & Chief Executive Officer, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference to be held November ...
Forbes.com - November 12, 2009 6:24 AM
BusinessWire - BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President & Chief Executive Officer, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference to be held November ...
Forbes.com - November 12, 2009 6:22 AM
BusinessWire - BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President & Chief Executive Officer, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference to be held November ...
Reuters - September 03, 2009 5:57 AM
RALEIGH, N.C.--(Business Wire)-- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced its participation in the following upcoming investor conferences: * Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences, ...
